122 related articles for article (PubMed ID: 35595099)
21. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280
[TBL] [Abstract][Full Text] [Related]
22. Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway.
Tian Y; Shen L; Li F; Yang J; Wan X; Ouyang M
J Cell Physiol; 2020 Jan; 235(1):442-453. PubMed ID: 31332784
[TBL] [Abstract][Full Text] [Related]
23. The translational regulator eIF3a: the tricky eIF3 subunit!
Saletta F; Suryo Rahmanto Y; Richardson DR
Biochim Biophys Acta; 2010 Dec; 1806(2):275-86. PubMed ID: 20647036
[TBL] [Abstract][Full Text] [Related]
24. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
25. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
Tee AR; Manning BD; Roux PP; Cantley LC; Blenis J
Curr Biol; 2003 Aug; 13(15):1259-68. PubMed ID: 12906785
[TBL] [Abstract][Full Text] [Related]
26. DNA-dependent protein kinase regulates lysosomal AMP-dependent protein kinase activation and autophagy.
Puustinen P; Keldsbo A; Corcelle-Termeau E; Ngoei K; Sønder SL; Farkas T; Kaae Andersen K; Oakhill JS; Jäättelä M
Autophagy; 2020 Oct; 16(10):1871-1888. PubMed ID: 31983282
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27.
Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR
Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199
[TBL] [Abstract][Full Text] [Related]
28. Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis.
Li XW; Wu YH; Li XH; Li D; Du J; Hu CP; Li YJ
Eur J Pharmacol; 2015 Feb; 749():89-97. PubMed ID: 25592322
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA screening from EIF3a in lung cancer.
Huang MS; Yuan FQ; Gao Y; Liu JY; Chen YX; Wang CJ; He BM; Zhou HH; Liu ZQ
Cancer Med; 2019 Aug; 8(9):4159-4168. PubMed ID: 31197975
[TBL] [Abstract][Full Text] [Related]
30. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
[TBL] [Abstract][Full Text] [Related]
31. The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.
Chen J; Liu JY; Dong ZZ; Zou T; Wang Z; Shen Y; Zhuo W; Li XP; Xiao D; Liu HT; Chen X; Zhou HH; Liu ZQ; Zhang JT; Yin JY
Biochem Pharmacol; 2021 Aug; 190():114616. PubMed ID: 34022189
[TBL] [Abstract][Full Text] [Related]
32. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
33. The cholangiocyte marker, BD. 1, forms a stable complex with CLIP170 and shares an identity with eIF3a, a multifunctional subunit of the eIF3 initiation complex.
Mills DR; Rozich RA; Flanagan DL; Brilliant KE; Yang D; Hixson DC
Exp Mol Pathol; 2012 Oct; 93(2):250-60. PubMed ID: 22613460
[TBL] [Abstract][Full Text] [Related]
34. Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuR.
Dong Z; Liu J; Zhang JT
Biochem J; 2020 May; 477(10):1939-1950. PubMed ID: 32391557
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth.
Wang Y; Hong X; Wang J; Yin Y; Zhang Y; Zhou Y; Piao HL; Liang Z; Zhang L; Li G; Xu G; Kwiatkowski DJ; Liu Y
Oncogene; 2017 Feb; 36(6):756-765. PubMed ID: 27399332
[TBL] [Abstract][Full Text] [Related]
36. eIF3a: A new anticancer drug target in the eIF family.
Yin JY; Zhang JT; Zhang W; Zhou HH; Liu ZQ
Cancer Lett; 2018 Jan; 412():81-87. PubMed ID: 29031564
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1.
Zheng M; Wang YH; Wu XN; Wu SQ; Lu BJ; Dong MQ; Zhang H; Sun P; Lin SC; Guan KL; Han J
Nat Cell Biol; 2011 Mar; 13(3):263-72. PubMed ID: 21336308
[TBL] [Abstract][Full Text] [Related]
38. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair.
Yin JY; Shen J; Dong ZZ; Huang Q; Zhong MZ; Feng DY; Zhou HH; Zhang JT; Liu ZQ
Clin Cancer Res; 2011 Jul; 17(13):4600-9. PubMed ID: 21610145
[TBL] [Abstract][Full Text] [Related]
39. The Role of miR-497/EIF3A Axis in TGFβ1-Induced Epithelial-Mesenchymal Transition and Extracellular Matrix in Rat Alveolar Epithelial Cells and Pulmonary Fibroblasts.
Guo R; Lv Y; Ouyang Y; Liu S; Li D
J Cell Biochem; 2017 Oct; 118(10):3401-3408. PubMed ID: 28322466
[TBL] [Abstract][Full Text] [Related]
40. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.
Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D
Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
